Advertisement

The Neuropathology Of Parkinson’S Disease

The Lewy body as a clue to the nerve cell degeneration
  • Lysia S. Forno
Chapter

Abstract

The etiology and pathogenesis of Parkinson’s disease have remained a mystery since the first description of the disease, but the neuropathology of the disorder, as we now know it, is fairly simple and straightforward. The most important lesion is in the substantia nigra pars compacta, where nerve cells degenerate together with their nigro-striatal fiber tract, causing a severe depletion of dopamine in the basal ganglia.

Keywords

Tyrosine Hydroxylase Substantia Nigra Nerve Cell Lewy Body Neurofibrillary Tangle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20:415–455PubMedCrossRefGoogle Scholar
  2. Bethlem J, Jager WAdH. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson’s disease). J Neurol Neurosurg Psychiatry 1960; 23:74–80PubMedCrossRefGoogle Scholar
  3. Cork LC, Sternberger NH, Sternberger LA, Casanova MF, Struble RG, Price DL. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer’s disease. J Neuropathol Exp Neurol 1986; 45:56–64PubMedCrossRefGoogle Scholar
  4. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson’s disease. J Neuropathol Exp Neurol 1965; 24:398–414CrossRefGoogle Scholar
  5. Forno LS. Pathology of Parkinson’s disease. In: Marsden CD, Fahn S, eds. Movement Disorders. London, Butterworth Scientific. 1982:25–40Google Scholar
  6. Forno LS. The Lewy body In Parkinson’s disease. In: Yahr MD, Bergmann KJ, eds. Advances in Neurology, New York, Raven Press 1987; 45:35–43Google Scholar
  7. Forno LS, Langston JW. The amygdala-parahippocampal region. A predilection site for Lewy bodies. J Neuropathol Exp Neurol 1988 (abstract; in press)Google Scholar
  8. Forno LS, Sternberger LA, Sternberger NH, Strefling AM, Swanson K, Eng LF. Reaction of Lewy bodies with antibodies to phosphorylated non-phosphorylated neurofilaments. Neurosci Lett 1986; 64:253–258PubMedCrossRefGoogle Scholar
  9. Galloway P, Grundke-Iqbal I, Autilio-Gambetti L, Gambetti P, Perry G. Neuronal cytoskeletal involvement in Lewy body formation. J Neuropathol Exp Neurol 1987; 46:374CrossRefGoogle Scholar
  10. Goldman JE, Yen S-H, Chiu FC, Peress NS. Lewy bodies of Parkinson’s disease contain neurofilament antigen. Science 1983; 221:1082–1084PubMedCrossRefGoogle Scholar
  11. Greenfield JG, Bosanquet FD. The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 1953; 16:213–226PubMedCrossRefGoogle Scholar
  12. Hallervorden J. Paralysis agitans (Anhang: Essentieller Tremor). In: Lubarsch O, Henke F, Rossle, eds. Handbuch der speziellen pathologischen Anatomie und Histologie. Berlin, Springer 1957; 13 (1A):900–924Google Scholar
  13. Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938; 48:387–476Google Scholar
  14. Hirano A. Neurons, astrocytes and ependyma. In Davis RL, Robertson, DM, eds. Textbook of Neuropathology. Baltimore, Williams & Wilkins 1985: 1–91Google Scholar
  15. Hirsch E, Ruberg M, Dardenne M, Portier M-M, Javoy-Agid F, Bach J-F, Agid Y. Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson’s disease. Brain Research, 1985; 345:374–378PubMedCrossRefGoogle Scholar
  16. Jager WAdH, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960; 283–290Google Scholar
  17. Jellinger K, Riederer P. Dementia in Parkinson’s disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity. In: Hassler RG, Christ JF, eds. Advances in Neurology. New York, Raven Press. 1984; 40:199–210Google Scholar
  18. Kahn J, Anderton BH. Gibb WRG, Lees AJ, Wells FR, Marsden CD. Neuronal filaments in Alzheimer’s, Pick’s, and Parkinson’s diseases. N Engl J Med 1985; 313:520–521PubMedCrossRefGoogle Scholar
  19. Kahn J, Anderton BH, Brion, J-P, Cowell I, Dale G, Kilford L. Marsden CD, Parke J, Robinson P. Im-munocytochemical staining of Lewy bodies with antibodies to cytoskeletal proteins. In: Marsden, CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson’s disease. Florham, New Jersey, Macmillan Healthcare Information 1987; volume 2:15–23Google Scholar
  20. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropathol 1984; 3:185–192PubMedGoogle Scholar
  21. Kuzuhara S., Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated. A light and electron-microscopic immunocytochemical study. Acta Neuropathol 1988 (in press)Google Scholar
  22. Lewy FH. Paralysis agitans. I. Pathologische Anatomie. In: Lewandowsky M, ed. Handbuch der Neurologie. Berlin, Springer; 1912:920–933Google Scholar
  23. Lewy FH. Die Lehre vom Tonus und der Bewegung. Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis Agitans. Berlin, Springer 1923Google Scholar
  24. Mori H. Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer’s disease. Science 1987;235:1641–1444PubMedCrossRefGoogle Scholar
  25. Munoz-Garcia D, Ludwin SK. Classic and generalized variants of Pick’s disease. A clinicopathological, ultrastructural and immunocytochemical comparative study. Ann Neurol 1984; 16:467–480PubMedCrossRefGoogle Scholar
  26. Nakashima S, Ikuta F. Tyrosine hydroxylase protein in Lewy bodies of parkinsonian und senile brains. J Neurol Sci 1984; 66:91–96PubMedCrossRefGoogle Scholar
  27. Pappola MA. Lewy bodies of Parkinson’s disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments. Arch Pathol Lab Med 1986; 110:1160–1163Google Scholar
  28. Quinn N, Critchley P, Marsden CD. Young onset Parkinson’s disease. Movement Disorders 1987; 2:73–91PubMedCrossRefGoogle Scholar
  29. Rasool CG. Selkoe DJ. Sharing of specific antigens by degenerating neurons in Pick’s disease and Alzheimer’s disease. N Engl J Med 1985; 312:700–705PubMedCrossRefGoogle Scholar
  30. Rechsteiner M. Ubiquitin-mediated pathways for intracellular proteolysis. Ann Rev Cell Biol 1957; 3:1–30CrossRefGoogle Scholar
  31. Sima AAF, Clark AW, Sternberger NH, Sternberger LA, Lewy body dementia without Alzheimer changes. Can J Neurol Sci 1986; 13:490–497PubMedGoogle Scholar
  32. Sternberger NH, Sternberger LA, Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer’s disease. Proc Natl Acad Sci USA 1985; 82 4274–4276PubMedCrossRefGoogle Scholar
  33. Tiller-Borcich JK, Forno LS. Parkinson’s disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies? J Neuropathol Exp Neurol 1988 (in press)Google Scholar
  34. Wischik CM, Crowther RA. Subunit structure of the Alzheimer tangle. British Medical Bulletin 1986; 42:51–56PubMedGoogle Scholar
  35. Yokochi M, Narabayashi H, Iizuka R, Nagatsu T. Juvenile parkinsonism — some clinical, pharmacological and neuropathological aspects. In Hassler RG, Christ JF, eds. Advances in Neurology, New York, Raven Press 1984; 40:407–413Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Lysia S. Forno
    • 1
    • 2
  1. 1.Departments of PathologyVeterans Administration Medical CenterPalo AltoUSA
  2. 2.Stanford University School of MedicineStanfordUSA

Personalised recommendations